Literature DB >> 8879128

High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA.

M Kameoka1, T Kimura, Y Okada, K Fujinaga, T Nakaya, H Takahashi, M Kishi, K Ikuta.   

Abstract

Our previous report showed that U937-derived subclones were differentiated into at least three types (high, middle, and low types), even in the subclones expressing similar levels of surface CD4, in terms of the kinetics of the appearance of viral antigens and virus production after infection with human immunodeficiency virus type 1 (HIV-1). Here we showed the evidence that high susceptibility to HIV-1 infection, which was confirmed by the profound expression of viral messages and antigens, was exclusively associated with a high number of the unintegrated extrachromosomal form of viral DNA, but not with the amounts of adsorbed virus RNA nor those of integrated DNA form. The difference in the amounts of extrachromosomal form of viral DNA was also observed in the culture with 3'-azido-3'-deoxythymidine (AZT), indicating that the susceptibility is essentially unrelated to multiple infection events. Thus, the susceptibility of U937-derived subclones to HIV-1 infection seems to be affected by the occurrence of specific events involved in the accumulation of unintegrated viral DNA after viral adsorption.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879128     DOI: 10.1007/bf00572950

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  74 in total

1.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

2.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

3.  Integration is essential for efficient gene expression of human immunodeficiency virus type 1.

Authors:  H Sakai; M Kawamura; J Sakuragi; S Sakuragi; R Shibata; A Ishimoto; N Ono; S Ueda; A Adachi
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.

Authors:  N L Michael; T Mo; A Merzouki; M O'Shaughnessy; C Oster; D S Burke; R R Redfield; D L Birx; S A Cassol
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

5.  HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.

Authors:  K Tenner-Racz; P Racz; M Bofill; A Schulz-Meyer; M Dietrich; P Kern; J Weber; A J Pinching; F Veronese-Dimarzo; M Popovic
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

6.  HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.

Authors:  B Hofmann; K D Jakobsen; N Odum; E Dickmeiss; P Platz; L P Ryder; C Pedersen; L Mathiesen; I B Bygbjerg; V Faber
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

7.  High susceptibility of U937-derived subclones to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation.

Authors:  M Kameoka; T Kimura; Y Okada; T Nakaya; M Kishi; K Ikuta
Journal:  Immunopharmacology       Date:  1995-06

8.  Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS.

Authors:  P Gupta; L Kingsley; J Armstrong; M Ding; M Cottrill; C Rinaldo
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

9.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.

Authors:  Y Nishino; T Nakaya; K Fujinaga; M Kishi; I Azuma; K Ikuta
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

View more
  2 in total

1.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Viral complementation allows HIV-1 replication without integration.

Authors:  Huub C Gelderblom; Dimitrios N Vatakis; Sean A Burke; Steven D Lawrie; Gregory C Bristol; David N Levy
Journal:  Retrovirology       Date:  2008-07-09       Impact factor: 4.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.